Key facts
- It has raised $30K; the latest was Seed Round in Dec 2024.
- Notable investors include MedTech Innovator, IKP EDEN, BHARAT IMPACT, Department of Pharmaceutical Management, Mercatus Center Emergent Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for RNT Health Insights
- ·The full record, as it builds
Funding rounds
No funding rounds for RNT Health Insights are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RNT Health Insights
Developer of an AI-assisted early gastric cancer detection software as a medical device solution designed to improve the efficiency and accuracy of detection and diagnosis of early gastric cancer. The company develops and offers a tool that integrates with endoscopy and utilizes novel algorithms to analyze real-time endoscopic imaging for lesion detection, enabling endoscopists to achieve precision and enhanced real-time diagnostic capabilities.
- Sector
- Healthcare
- HQ
- Chandigarh, India
- Founded
- 2022
- Employees
- 8
- Website
- rntinsights.com/
- Ownership
- Privately Held (backing)
RNT Health Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RNT Health Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RNT Health Insights in its N-PORT filings yet. We sweep new filings monthly.